Wednesday, April 20, 2011

Exploring the Challenges of Neonatal and Pediatric Medication Safety

This came out yesterday:

Baxa Webinar to Explore Challenges of Neonatal and Pediatric Medication Safety

Educational webinar addresses strategies to decrease medication errors when treating young patient population.

Englewood, Colorado - Baxa Corporation today announced that it will offer an educational webinar to discuss the challenges of neonatal and pediatric medication safety. Titled "Confronting the Challenges of Neonatal and Pediatric Medication Safety," the interactive event will be led by Michelle Mandrack, RN, MSN - Director of Consulting Services at the Institute for Safe Medication Practices (ISMP).

The webinar will take place on April 26, 2011 from 1-2:00 PM ET and provides one CE credit to qualified attendees. To register for "Confronting the Challenges of Neonatal and Pediatric Medication Safety," go to or call 800.567.BAXA.

Mandrack will share some of ISMP's insights to help participants:
  • Identify reasons why neonatal and pediatric patients are at high risk for medication errors;
  • Discuss common medication errors that occur in pediatric and neonatal populations; and
  • Describe strategies to decrease the risk related to neonatal and pediatric medication use.
Speaker Michelle Mandrack has more than 20 years of experience as an acute care nurse. ISMP is a nonprofit organization that is known and respected worldwide as the premier resource for timely, impartial, and accurate medication safety information.

"Unique treatment considerations for neonatal and pediatric patients make them more vulnerable to serious medication errors than adults," says Mandrack. "The entire healthcare team needs to recognize the areas of risk and work together to implement effective safeguards to prevent harm."

Founded in 1975, Baxa Corporation supports medication safety and error reduction in the pharmacy and across the healthcare landscape. Baxa continues to lead the industry with ExactaMed® Syringes; the most widely used oral syringes on the market for pediatric and neonatal patient populations. In addition, the NeoThrive® Enteral System for neonatal feedings helps to prevent risk of misconnection error.

For more information about Baxa Corporation, visit or call 800.567.BAXA. For more information about ISMP visit or call 215-947-7797.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging and administration of medications. Key products used worldwide in hospitals and healthcare facilities include: the Abacus® Order Entry and Calculation Software, the DoseEdge® Pharmacy Workflow Manager , ExactaMed® Oral Syringes, ExactaMix® Automated Compounding Devices , InFuse™ and MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, NeoThrive® Enteral Syringes, the PadLock® Set Saver and the RapidFill™ and IntelliFill® i.v. Automated Syringe Fillers. Privately held, Baxa Corporation has subsidiaries and sales offices in Florida, Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide.

No comments:

Post a Comment